Results 141 to 150 of about 18,054 (205)

Overcoming the sorafenib resistance mechanism in FLT3-mutated acute myeloid leukemia: molecular basis and new targets. [PDF]

Front Oncol
Peng H, Li M, Peng YY, Li XL, Yang J, Sun QG, Song K.   +6 more
europepmc   +1 more source

TKD XIII. Genel Kurul Gündemi

Türk Kütüphaneciliği, 1988
openaire   +1 more source

Midostaurin response in AML is shaped by a progenitor-like cell state selectively targeted by SMAC mimetics. [PDF]

NPJ Precis Oncol
Struyf N, Gezelius H, Lundmark A, Barizza C, Ploeger H, Rico Pizarro L, Vesterlund M, Mermelekas G, Österroos A, Bohlin A, Bengtzén S, Hamberg Levedahl K, Jafari R, Orre LM, Lehtiö J, Östling P, Seashore-Ludlow B, Nordlund J, Lehmann S, Kallioniemi O, Erkers T.   +20 more
europepmc   +1 more source

TKD VIII. GENEL KURUL TOPLANTISI

Türk Kütüphaneciliği, 1976
openaire   +2 more sources

Bridging experiments and defects' mechanics: a data-driven toolbox for configurational force analysis. [PDF]

Eng Comput
Koko A, Abdelnour A, Becker TH, Marrow TJ.   +3 more
europepmc   +1 more source

TKD XIII. Genel Kurul Açılış Konuşması

Türk Kütüphaneciliği, 1988
openaire   +1 more source

Aberrant CD25 and Increased CD123 Expression Are Common in Acute Myeloid Leukemia with KMT2A Partial Tandem Duplication and Are Associated with FLT3 Internal Tandem Duplication. [PDF]

Cancers (Basel)
Wei Q, Tang G, Li S, Wang SA, Lin P, Wang W, Loghavi S, Wang WJ, Medeiros LJ, Xu J.   +9 more
europepmc   +1 more source